-
1
-
-
0036892977
-
Changing international trends in mortality rates for liver, biliary and pancreatic tumours
-
Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol. 2002;37(6):806-13.
-
(2002)
J Hepatol
, vol.37
, Issue.6
, pp. 806-813
-
-
Khan, S.A.1
Taylor-Robinson, S.D.2
Toledano, M.B.3
Beck, A.4
Elliott, P.5
Thomas, H.C.6
-
2
-
-
84896723581
-
New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma
-
Patel T. New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma. J Gastroenterol. 2014;49(2):165-72.
-
(2014)
J Gastroenterol
, vol.49
, Issue.2
, pp. 165-172
-
-
Patel, T.1
-
3
-
-
56349107784
-
Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma
-
Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N. Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma. World J Surg. 2008;32(12):2675-80.
-
(2008)
World J Surg
, vol.32
, Issue.12
, pp. 2675-2680
-
-
Nakagohri, T.1
Kinoshita, T.2
Konishi, M.3
Takahashi, S.4
Gotohda, N.5
-
4
-
-
79952113171
-
Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality
-
Hirano S, Kondo S, Tanaka E, Shichinohe T, Tsuchikawa T, Kato K, et al. Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. J Hepatobiliary Pancreat Sci. 2010;17(4):455-62.
-
(2010)
J Hepatobiliary Pancreat Sci
, vol.17
, Issue.4
, pp. 455-462
-
-
Hirano, S.1
Kondo, S.2
Tanaka, E.3
Shichinohe, T.4
Tsuchikawa, T.5
Kato, K.6
Matsumoto, J.7
Kawasaki, R.8
-
5
-
-
15944425099
-
Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins
-
Sakamoto Y, Kosuge T, Shimada K, Sano T, Ojima H, Yamamoto J, et al. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins. Surgery. 2005;137(4):396-402.
-
(2005)
Surgery
, vol.137
, Issue.4
, pp. 396-402
-
-
Sakamoto, Y.1
Kosuge, T.2
Shimada, K.3
Sano, T.4
Ojima, H.5
Yamamoto, J.6
Yamasaki, S.7
Takayama, T.8
Makuuchi, M.9
-
6
-
-
58049170380
-
The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer
-
Acquaviva J, Wong R, Charest A. The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer. Biochim Biophys Acta. 2009;1795(1):37-52.
-
(2009)
Biochim Biophys Acta
, vol.1795
, Issue.1
, pp. 37-52
-
-
Acquaviva, J.1
Wong, R.2
Charest, A.3
-
7
-
-
36849065315
-
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer
-
Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007;131(6):1190-203.
-
(2007)
Cell
, vol.131
, Issue.6
, pp. 1190-1203
-
-
Rikova, K.1
Guo, A.2
Zeng, Q.3
Possemato, A.4
Yu, J.5
Haack, H.6
Nardone, J.7
Lee, K.8
Reeves, C.9
Li, Y.10
-
8
-
-
84863338079
-
ROS1 rearrangements define a unique molecular class of lung cancers
-
Bergethon K, Shaw AT, Ou SH, Katayama R, Lovly CM, McDonald NT, et al. ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol. 2012;30(8):863-70.
-
(2012)
J Clin Oncol
, vol.30
, Issue.8
, pp. 863-870
-
-
Bergethon, K.1
Shaw, A.T.2
Ou, S.H.3
Katayama, R.4
Lovly, C.M.5
McDonald, N.T.6
Massion, P.P.7
Siwak-Tapp, C.8
Gonzalez, A.9
Fang, R.10
-
9
-
-
84857985225
-
RET, ROS1 and ALK fusions in lung cancer
-
Takeuchi K, Soda M, Togashi Y, Suzuki R, Sakata S, Hatano S, et al. RET, ROS1 and ALK fusions in lung cancer. Nat Med. 2012;18(3):378-81.
-
(2012)
Nat Med
, vol.18
, Issue.3
, pp. 378-381
-
-
Takeuchi, K.1
Soda, M.2
Togashi, Y.3
Suzuki, R.4
Sakata, S.5
Hatano, S.6
Asaka, R.7
Hamanaka, W.8
Ninomiya, H.9
Uehara, H.10
-
10
-
-
84865089246
-
Analysis of receptor tyrosine kinase ROS1-positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusion
-
Rimkunas VM, Crosby KE, Li D, Hu Y, Kelly ME, Gu TL, et al. Analysis of receptor tyrosine kinase ROS1-positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusion. Clin Cancer Res. 2012;18(16):4449-57.
-
(2012)
Clin Cancer Res
, vol.18
, Issue.16
, pp. 4449-4457
-
-
Rimkunas, V.M.1
Crosby, K.E.2
Li, D.3
Hu, Y.4
Kelly, M.E.5
Gu, T.L.6
Mack, J.S.7
Silver, M.R.8
Zhou, X.9
Haack, H.10
-
11
-
-
84866434919
-
Genomic landscape of non-small cell lung cancer in smokers and never-smokers
-
Govindan R, Ding L, Griffith M, Subramanian J, Dees ND, Kanchi KL, et al. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell. 2012;150(6):1121-34.
-
(2012)
Cell
, vol.150
, Issue.6
, pp. 1121-1134
-
-
Govindan, R.1
Ding, L.2
Griffith, M.3
Subramanian, J.4
Dees, N.D.5
Kanchi, K.L.6
Maher, C.A.7
Fulton, R.8
Fulton, L.9
Wallis, J.10
-
12
-
-
0037402509
-
Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21)
-
Charest A, Lane K, McMahon K, Park J, Preisinger E, Conroy H, et al. Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21). Genes Chromosomes Cancer. 2003;37(1):58-71.
-
(2003)
Genes Chromosomes Cancer
, vol.37
, Issue.1
, pp. 58-71
-
-
Charest, A.1
Lane, K.2
McMahon, K.3
Park, J.4
Preisinger, E.5
Conroy, H.6
Housman, D.7
-
13
-
-
84876666653
-
Identification of ROS1 rearrangement in gastric adenocarcinoma
-
Lee J, Lee SE, Kang SY, Do IG, Lee S, Ha SY, et al. Identification of ROS1 rearrangement in gastric adenocarcinoma. Cancer. 2013;119(9):1627-35.
-
(2013)
Cancer
, vol.119
, Issue.9
, pp. 1627-1635
-
-
Lee, J.1
Lee, S.E.2
Kang, S.Y.3
Do, I.G.4
Lee, S.5
Ha, S.Y.6
Cho, J.7
Kang, W.K.8
Jang, J.9
Ou, S.H.10
-
14
-
-
84893116875
-
ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers
-
Aisner DL, Nguyen TT, Paskulin DD, Le AT, Haney J, Schulte N, et al. ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers. Mol Cancer Res. 2014;12(1):111-8.
-
(2014)
Mol Cancer Res
, vol.12
, Issue.1
, pp. 111-118
-
-
Aisner, D.L.1
Nguyen, T.T.2
Paskulin, D.D.3
Le, A.T.4
Haney, J.5
Schulte, N.6
Chionh, F.7
Hardingham, J.8
Mariadason, J.9
Tebbutt, N.10
-
15
-
-
84911372597
-
Crizotinib in ROS1-rearranged non-small-cell lung cancer
-
Shaw AT, Ou SH, Bang YJ, Camidge DR, Solomon BJ, Salgia R, et al. Crizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl J Med. 2014;371(21):1963-71.
-
(2014)
N Engl J Med
, vol.371
, Issue.21
, pp. 1963-1971
-
-
Shaw, A.T.1
Ou, S.H.2
Bang, Y.J.3
Camidge, D.R.4
Solomon, B.J.5
Salgia, R.6
Riely, G.J.7
Varella-Garcia, M.8
Shapiro, G.I.9
Costa, D.B.10
-
16
-
-
84881245421
-
Molecular pathways: ROS1 fusion proteins in cancer
-
Davies KD, Doebele RC. Molecular pathways: ROS1 fusion proteins in cancer. Clin Cancer Res. 2013;19(15):4040-5.
-
(2013)
Clin Cancer Res
, vol.19
, Issue.15
, pp. 4040-4045
-
-
Davies, K.D.1
Doebele, R.C.2
-
17
-
-
79251579592
-
Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma
-
Gu TL, Deng X, Huang F, Tucker M, Crosby K, Rimkunas V, et al. Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS One. 2011;6(1), e15640.
-
(2011)
PLoS One
, vol.6
, Issue.1
-
-
Gu, T.L.1
Deng, X.2
Huang, F.3
Tucker, M.4
Crosby, K.5
Rimkunas, V.6
Wang, Y.7
Deng, G.8
Zhu, L.9
Tan, Z.10
-
18
-
-
77954818058
-
The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM
-
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471-4.
-
(2010)
Ann Surg Oncol
, vol.17
, Issue.6
, pp. 1471-1474
-
-
Edge, S.B.1
Compton, C.C.2
-
19
-
-
79960001615
-
Pathological classification of intrahepatic cholangiocarcinoma based on a new concept
-
Nakanuma Y, Sato Y, Harada K, Sasaki M, Xu J, Ikeda H. Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. World J Hepatol. 2010;2(12):419-27.
-
(2010)
World J Hepatol
, vol.2
, Issue.12
, pp. 419-427
-
-
Nakanuma, Y.1
Sato, Y.2
Harada, K.3
Sasaki, M.4
Xu, J.5
Ikeda, H.6
-
20
-
-
0242522356
-
Intrahepatic cholangiocarcinoma: macroscopic type and stage classification
-
Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg. 2003;10(4):288-91.
-
(2003)
J Hepatobiliary Pancreat Surg
, vol.10
, Issue.4
, pp. 288-291
-
-
Yamasaki, S.1
-
21
-
-
67349170855
-
Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection
-
Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, et al. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg. 2009;33(6):1247-54.
-
(2009)
World J Surg
, vol.33
, Issue.6
, pp. 1247-1254
-
-
Guglielmi, A.1
Ruzzenente, A.2
Campagnaro, T.3
Pachera, S.4
Valdegamberi, A.5
Nicoli, P.6
Cappellani, A.7
Malfermoni, G.8
Iacono, C.9
-
22
-
-
84888362036
-
Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic target
-
Saborowski A, Saborowski M, Davare MA, Druker BJ, Klimstra DS, Lowe SW. Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic target. Proc Natl Acad Sci U S A. 2013;110(48):19513-8.
-
(2013)
Proc Natl Acad Sci U S A
, vol.110
, Issue.48
, pp. 19513-19518
-
-
Saborowski, A.1
Saborowski, M.2
Davare, M.A.3
Druker, B.J.4
Klimstra, D.S.5
Lowe, S.W.6
-
23
-
-
84888333580
-
Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins
-
Davare MA, Saborowski A, Eide CA, Tognon C, Smith RL, Elferich J, et al. Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins. Proc Natl Acad Sci U S A. 2013;110(48):19519-24.
-
(2013)
Proc Natl Acad Sci U S A
, vol.110
, Issue.48
, pp. 19519-19524
-
-
Davare, M.A.1
Saborowski, A.2
Eide, C.A.3
Tognon, C.4
Smith, R.L.5
Elferich, J.6
Agarwal, A.7
Tyner, J.W.8
Shinde, U.P.9
Lowe, S.W.10
-
24
-
-
80052055991
-
ROS receptor tyrosine kinase: a new potential target for anticancer drugs
-
El-Deeb IM, Yoo KH, Lee SH. ROS receptor tyrosine kinase: a new potential target for anticancer drugs. Med Res Rev. 2011;31(5):794-818.
-
(2011)
Med Res Rev
, vol.31
, Issue.5
, pp. 794-818
-
-
El-Deeb, I.M.1
Yoo, K.H.2
Lee, S.H.3
-
25
-
-
84904618342
-
Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma
-
Graham RP, Barr Fritcher EG, Pestova E, Schulz J, Sitailo LA, Vasmatzis G, et al. Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma. Hum Pathol. 2014.
-
(2014)
Hum Pathol
-
-
Graham, R.P.1
Barr Fritcher, E.G.2
Pestova, E.3
Schulz, J.4
Sitailo, L.A.5
Vasmatzis, G.6
-
26
-
-
84907948624
-
Screening for the FIG-ROS1 fusion in biliary tract carcinomas by nested PCR
-
Peraldo Neia C, Cavalloni G, Balsamo A, Venesio T, Napoli F, Sassi F, et al. Screening for the FIG-ROS1 fusion in biliary tract carcinomas by nested PCR. Genes Chromosomes Cancer. 2014;53(12):1033-40.
-
(2014)
Genes Chromosomes Cancer
, vol.53
, Issue.12
, pp. 1033-1040
-
-
Peraldo Neia, C.1
Cavalloni, G.2
Balsamo, A.3
Venesio, T.4
Napoli, F.5
Sassi, F.6
Martin, V.7
Frattini, M.8
Aglietta, M.9
Leone, F.10
-
27
-
-
84904372791
-
ROS kinase fusions are not common in Chinese patients with cholangiocarcinoma
-
Liu P, Wu Y, Sun L, Zuo Q, Shi M. ROS kinase fusions are not common in Chinese patients with cholangiocarcinoma. Nan Fang Yi Ke Da Xue Xue Bao. 2013;33(4):474-8.
-
(2013)
Nan Fang Yi Ke Da Xue Xue Bao
, vol.33
, Issue.4
, pp. 474-478
-
-
Liu, P.1
Wu, Y.2
Sun, L.3
Zuo, Q.4
Shi, M.5
-
28
-
-
80052552459
-
Clinical diagnosis and staging of cholangiocarcinoma
-
Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;8(9):512-22.
-
(2011)
Nat Rev Gastroenterol Hepatol
, vol.8
, Issue.9
, pp. 512-522
-
-
Blechacz, B.1
Komuta, M.2
Roskams, T.3
Gores, G.J.4
-
29
-
-
84870879515
-
Classification, diagnosis, and management of cholangiocarcinoma
-
Razumilava N, Gores GJ. Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol. 2013;11(1):13-21. e11; quiz e13-14.
-
(2013)
Clin Gastroenterol Hepatol
, vol.11
, Issue.1
, pp. 13-21
-
-
Razumilava, N.1
Gores, G.J.2
-
30
-
-
84904384871
-
ROS1 expression and translocations in non-small-cell lung cancer: clinicopathological analysis of 1478 cases
-
Warth A, Muley T, Dienemann H, Goeppert B, Stenzinger A, Schnabel PA, et al. ROS1 expression and translocations in non-small-cell lung cancer: clinicopathological analysis of 1478 cases. Histopathology. 2014.
-
(2014)
Histopathology
-
-
Warth, A.1
Muley, T.2
Dienemann, H.3
Goeppert, B.4
Stenzinger, A.5
Schnabel, P.A.6
-
31
-
-
84871784888
-
ROS1 receptor tyrosine kinase, a druggable target, is frequently overexpressed in non-small cell lung carcinomas via genetic and epigenetic mechanisms
-
Lee HJ, Seol HS, Kim JY, Chun SM, Suh YA, Park YS, et al. ROS1 receptor tyrosine kinase, a druggable target, is frequently overexpressed in non-small cell lung carcinomas via genetic and epigenetic mechanisms. Ann Surg Oncol. 2013;20(1):200-8.
-
(2013)
Ann Surg Oncol
, vol.20
, Issue.1
, pp. 200-208
-
-
Lee, H.J.1
Seol, H.S.2
Kim, J.Y.3
Chun, S.M.4
Suh, Y.A.5
Park, Y.S.6
Kim, S.W.7
Choi, C.M.8
Park, S.I.9
Kim, D.K.10
-
32
-
-
84875877241
-
ROS1 expression in invasive ductal carcinoma of the breast related to proliferation activity
-
Eom M, Lkhagvadorj S, Oh SS, Han A, Park KH. ROS1 expression in invasive ductal carcinoma of the breast related to proliferation activity. Yonsei Med J. 2013;54(3):650-7.
-
(2013)
Yonsei Med J
, vol.54
, Issue.3
, pp. 650-657
-
-
Eom, M.1
Lkhagvadorj, S.2
Oh, S.S.3
Han, A.4
Park, K.H.5
-
33
-
-
84884515755
-
ROS1 immunohistochemistry for detection of ROS1-rearranged lung adenocarcinomas
-
Sholl LM, Sun H, Butaney M, Zhang C, Lee C, Janne PA, et al. ROS1 immunohistochemistry for detection of ROS1-rearranged lung adenocarcinomas. Am J Surg Pathol. 2013;37(9):1441-9.
-
(2013)
Am J Surg Pathol
, vol.37
, Issue.9
, pp. 1441-1449
-
-
Sholl, L.M.1
Sun, H.2
Butaney, M.3
Zhang, C.4
Lee, C.5
Janne, P.A.6
Rodig, S.J.7
-
34
-
-
84892875156
-
On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas
-
Mescam-Mancini L, Lantuejoul S, Moro-Sibilot D, Rouquette I, Souquet PJ, Audigier-Valette C, et al. On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas. Lung Cancer. 2014;83(2):168-73.
-
(2014)
Lung Cancer
, vol.83
, Issue.2
, pp. 168-173
-
-
Mescam-Mancini, L.1
Lantuejoul, S.2
Moro-Sibilot, D.3
Rouquette, I.4
Souquet, P.J.5
Audigier-Valette, C.6
Sabourin, J.C.7
Decroisette, C.8
Sakhri, L.9
Brambilla, E.10
-
35
-
-
84899989532
-
Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers
-
Yoshida A, Tsuta K, Wakai S, Arai Y, Asamura H, Shibata T, et al. Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers. Mod Pathol. 2014;27(5):711-20.
-
(2014)
Mod Pathol
, vol.27
, Issue.5
, pp. 711-720
-
-
Yoshida, A.1
Tsuta, K.2
Wakai, S.3
Arai, Y.4
Asamura, H.5
Shibata, T.6
Furuta, K.7
Kohno, T.8
Kushima, R.9
-
36
-
-
84905016551
-
Downregulation of ROS-FIG inhibits cell proliferation, colonyformation, cell cycle progression, migration and invasion, while inducing apoptosis in intrahepatic cholangiocarcinoma cells
-
Deng G, Hu C, Zhu L, Huang F, Huang W, Xu H, et al. Downregulation of ROS-FIG inhibits cell proliferation, colonyformation, cell cycle progression, migration and invasion, while inducing apoptosis in intrahepatic cholangiocarcinoma cells. Int J Mol Med. 2014;34(3):661-8.
-
(2014)
Int J Mol Med
, vol.34
, Issue.3
, pp. 661-668
-
-
Deng, G.1
Hu, C.2
Zhu, L.3
Huang, F.4
Huang, W.5
Xu, H.6
Nie, W.7
|